Headquartered in Brandon, FL, privately-held Jointechlabs is an emerging worldwide leader in regenerative medicine.
The company enables healthcare practitioners to provide safe, cost-effective, non-surgical therapies at the point-of-care without change in infrastructure.
FDA-cleared MiniTC® is a stand-alone device for processing autologous fat into regenerative-cell-rich microfat. Microfat’s uses include a variety of orthopedic, aesthetic, wound healing, and reconstructive surgery applications. Additionally, in certain markets, CE-Mark-approved Mini-Stem System® extracts microfat and Stromal Vascular Fraction. Pipeline includes development of stem-cell based therapeutics with 3D Bioprinted constructs and injectable stem cell scaffolding.
Posts attributed to Jointechlabs may have been written by one or more staff members, consultants, or third parties.
More Information: https://www.jointechlabs.com.
Home Page: https://jointechlabs.com
MiniTC is well-known for microfat used in humans. In this presentation to IGNITE (formerly the Equine High-Performance Sports Group), Dr. Nathan Katz discusses microfat in humans and horses.
Jointechlabs’ expands in Europe with both Swiss regulatory approval and appointment of Drs. Markus Klingenberg and George A. Skarpas to the scientific advisory board.
Microfat has many compounds within it that science believe are beneficial. Of all the compounds, the most beneficial are regenerative cells. How many regenerative cells do you get from a microfat injection?
Jointechlabs appoints respected doctor and surgeon George A. Karpas to a new post as scientific clinical lead for EU studies.
Jointechlabs announced the first successful use of its groundbreaking medical device, Mini-Stem System® , in Italy, Greece, and Cyprus.
Mini-Stem System has received CE Mark approval
Excerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.
Renowned doctors Dr. William D. Murrell (orthopedics) and Dr. Carlos Mercado (aesthetics) bring new scientific and market savvy to the company.
BMAC and microfat both provide orthopedic advantages. Microfat can also be used when BMAC is not indicated.
“Join us on the Talk is Biotech! podcast as we chat with Nathan Katz about his incredible journey from completing his PhD to becoming a medical scientist and ultimately a successful CEO of Jointechlabs, Inc.”